Cargando…
miR-141-3p is Poorly Expressed in Polycystic Ovary Syndrome and Correlates with Glucose and Lipid Metabolism
Polycystic ovary syndrome (PCOS) is a common endocrinopathy with high prevalence. miR-141-3p downregulation was reported in PCOS rats. This study intended to investigate miR-141-3p expression in serum of PCOS patients and its correlation with glucose and lipid metabolism. A total of 100 PCOS patient...
Autores principales: | Fan, Lingye, Wang, Chunyan, Zhan, Ping, Liu, Yaofang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519708/ https://www.ncbi.nlm.nih.gov/pubmed/34659401 http://dx.doi.org/10.1155/2021/2022938 |
Ejemplares similares
-
LncRNA RBAT1 reduces chemosensitivity of cancer cells to carboplatin/paclitaxel by sponging miR‑27b in endometrial carcinoma
por: Fan, Lingye, et al.
Publicado: (2023) -
Correlation study on serum miR-222-3p and glucose and lipid metabolism in patients with polycystic ovary syndrome
por: Wang, Qin, et al.
Publicado: (2022) -
Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2020) -
Plasma Levels of miR-27a, miR-130b, and miR-301a in Polycystic Ovary Syndrome
por: Pourteymour Fard Tabrizi, Zahra, et al.
Publicado: (2020) -
Genetic Variants miR-126, miR-146a, miR-196a2, and miR-499 in Polycystic Ovary Syndrome
por: Li, R., et al.
Publicado: (2022)